Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2009-01-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0812090106PMID 19139414PMCID PMC2630078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.

  2008cited by this paper
• Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds.

  2008cited by this paper
• Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors

  2008cited by this paper
• A guide to murine coagulation factor structure, function, assays, and genetic alterations

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• Reprogramming somatic cells towards pluripotency by defined factors.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. I: Establishment of the differentiation protocol.

  2007cited by this paper
• Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1

  2006cited by this paper
• Sall4 Interacts with Nanog and Co-occupies Nanog Genomic Sites in Embryonic Stem Cells*

  2006cited by this paper
• Murine inner cell mass-derived lineages depend on Sall4 function

  2006cited by this paper
• Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

  2001cited by this paper
• Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors.

  2001cited by this paper
• Properties of Anti-Factor VIII Inhibitor Antibodies in Hemophilia A Patients

  2000cited by this paper
• Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin.

  2000influential reference
• Advances toward Gene Therapy for Hemophilia at the Millennium

  1999cited by this paper
• Human factor IX corrects the bleeding diathesis of mice with hemophilia B.

  1998cited by this paper
• Medaka spalt acts as a target gene of hedgehog signaling.

  1997cited by this paper
• Embryonic stem cells as a source of hematopoietic and vascular endothelial cells in vitro.

  1997cited by this paper
• Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps.

  1996cited by this paper
• Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

  1995influential reference
• Transition in cardiac contractile sensitivity to calcium during the in vitro differentiation of mouse embryonic stem cells

  1994cited by this paper
• Correction of the haemostatic defect in haemophiliacs without apparent correction of the coagulation defect.

  1974cited by this paper

• Therapeutic advances in hemophilia: from molecular innovation to patient-centered global care

  2025cites this paper
• The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes

  2025cites this paper
• Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives

  2024cites this paper
• Strategies for Hemophilia Treatment, a literature review of current evidence

  2023cites this paper
• In Vitro Conditioning of Adipose-Derived Mesenchymal Stem Cells by the Endothelial Microenvironment: Modeling Cell Responsiveness towards Non-Genetic Correction of Haemophilia A

  2022cites this paper
• Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs.

  2022cites this paper
• Global Trends of Stem Cell Precision Medicine Research (2018–2022): A Bibliometric Analysis

  2022cites this paper
• “Cutting the Mustard” with Induced Pluripotent Stem Cells: An Overview and Applications in Healthcare Paradigm

  2022cites this paper
• Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes

  2021cites this paper
• Therapeutic Cells and Stem Cells for Nerve Regeneration

  2021cites this paper
• Types and Classification of Stem Cells

  2021cites this paper
• Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells.

  2021cites this paper
• Cellular Reprogramming and Aging

  2020cites this paper
• Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A

  2020cites this paper
• Modelling multiple sclerosis using induced pluripotent stem cells.

  2020cites this paper
• Fetal liver stem cell transplantation for liver diseases.

  2019cites this paper
• Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.

  2019cites this paper
• ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs

  2019cites this paper
• Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A

  2018cites this paper
• Review

  2018cites this paper
• Stem cells and somatic cells reprogramming – selected issues

  2018cites this paper
• Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates

  2018influential citation
• In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A

  2018cites this paper
• Generation of reporter hESCs by targeting EGFP at the CD144 locus to facilitate the endothelial differentiation

  2018cites this paper
• 10 Searching for the Key to Expand Hematopoietic Stem Cells

  2017cites this paper
• Scientific section designation: THROMBOSIS AND HEMOSTASIS Title: A conditional knockout mouse model reveals endothelial cells as the predominant and possibly exclusive source of plasma factor VIII Short title: FVIII is synthesized by endothelial cells

  2017cites this paper
• The Construction and Identification of Induced Pluripotent Stem Cells Derived from Acute Myelogenous Leukemia Cells

  2017cites this paper
• Regenerative Medicine and the Biliary Tree

  2017cites this paper
• Ten years since the discovery of iPS cells: The current state of their clinical application.

  2017cites this paper
• Induced Pluripotent Stem Cells (iPSCs) and Nuclear Reprogramming

  2017cites this paper
• An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34+ cells

  2017cites this paper
• Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation

  2017cites this paper
• Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology

  2017cites this paper
• Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.

  2017cites this paper
• Ten years since the discovery of iPS cells: The current state of their clinical application

  2017cites this paper
• Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia

  2017cites this paper
• Ips Progression a Decade Devoted

  2017cites this paper
• Ips Progression a Decade Devoted

  2017cites this paper
• Therapeutic approaches for treating hemophilia A using embryonic stem cells.

  2016cites this paper
• In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs

  2016cites this paper
• Review of stem cell therapy: its production principles and therapeutic application in certain human and animal diseases

  2016cites this paper
• Stem Cell Therapy and Immunological Rejection in Animal Models.

  2016cites this paper
• TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice.

  2016cites this paper
• Actual strategies in human induced pluripotent stem cells ( hiPSCs ) differentiation – perspectives and challenges

  2016cites this paper
• Ten years since the discovery of iPS cells : The current state of their clinical application

  2016cites this paper
• iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System

  2016cites this paper
• Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.

  2016cites this paper
• Diez años desde el descubrimiento de las células IPS: estado actual de su aplicación clínica

  2016cites this paper
• Genome editing: An alternative to retroviral vectors for Wiskott-Aldrich Syndrome (WAS) Gene Therapy?

  2016cites this paper
• Hepatocyte-Like Cells Derived from Mouse Induced Pluripotent Stem Cells Produce Functional Coagulation Factor IX in a Hemophilia B Mouse Model

  2016cites this paper
• Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion

  2016cites this paper
• Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.

  2016cites this paper
• Synchronously Transgene of Therapeutic Intercalated Disc-related CX43 and ZO1 Genes and Reprogramming Genes does not Affect The Pluripotent of Pig IPS

  2015cites this paper
• Biological therapies for inherited diseases: social and bioethical considerations. Hemophilia as an example

  2015cites this paper
• 血友病A基因治疗的研究进展

  2015cites this paper
• Induced pluripotent stem cell and their applications inDrug Discovery and Precision Personalized Medicine

  2015cites this paper
• Cell mediated gene therapy: A guide for doctors in the clinic

  2015cites this paper
• Therapeutic Potential of Totipotent, Pluripotent and Multipotent Stem Cells

  2015cites this paper
• Induced Pluripotent Stem Cells as a Cell-Based Therapeutic in Stroke

  2015cites this paper
• Induced pluripotent stem cell and their applications in Drug Discovery and Precision Personalized Medicine

  2015cites this paper
• Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery

  2015cites this paper
• Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Cholangiocytes

  2015cites this paper
• Induced Pluripotent Stem Cell, a Rising Star in Regenerative Medicine

  2015cites this paper
• Gene therapy for hemophilia.

  2015cites this paper
• New approaches to gene and cell therapy for hemophilia

  2015cites this paper
• Application of Graphene Based Nanotechnology in Stem Cells Research.

  2015cites this paper
• The State of Play with iPSCs and Spinal Cord Injury Models

  2015cites this paper
• Development and Characterisation of AML-M5-Derived Induced Pluripotent Stem Cells (IPSCS)

  2015cites this paper
• Opracowanie nowej metody generowania ludzkich indukowanych komórek pluripotencjalnych (iPS) i wykazanie roli białka KAP1 w epigenetycznej regulacji procesu samoodnowy

  2015cites this paper
• Progress and challenges in the development of a cell‐based therapy for hemophilia A

  2014cites this paper
• A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.

  2014cites this paper
• Comparison of different protocols for neural differentiation of human induced pluripotent stem cells

  2014cites this paper
• Enabling Autologous Human Liver Regeneration with Differentiated Adipocyte Stem Cells

  2014cites this paper
• Establishment and identification of induced pluripotent stem cells in liver cancer patients.

  2014cites this paper
• CREATION OF BIOARTIFICIAL ORGANS

  2014cites this paper
• Human Stem Cells for Craniomaxillofacial Reconstruction

  2014cites this paper
• New iPSC for old long QT syndrome modeling: Putting the evidence into perspective

  2014cites this paper
• Induced pluripotent stem cells in regenerative medicine and disease modeling.

  2014cites this paper
• KAJIAN INDUCED PLURIPOTENT STEMCELL (iPS) (HARAPAN DAN TANTANGAN)

  2014cites this paper
• The Role of Cell-polarity in Development and Disease

  2014cites this paper
• Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.

  2014cites this paper
• Mice with humanized liver endothelium

  2014cites this paper
• Replacing bad (F)actors: hemophilia.

  2014cites this paper
• Generation and characterization of bat-induced pluripotent stem cells

  2014cites this paper
• Reprogramming hierarchy in mouse liver cell subpopulations depends on cell intrinsic factors including BAF complex members.

  2014cites this paper
• Chapter 2 – Pluripotent Stem Cells and Gene Therapy

  2014cites this paper
• Basic biology and therapeutic application of stem cells in various human and animal diseases

  2014cites this paper
• Production of functional coagulation factor VIII from iPSCs using a lentiviral vector

  2014cites this paper
• Novel Regulators of Somatic Cell Reprogramming

  2014influential citation
• Induction of Estrogen-Sensitive Epithelial Cells Derived from Human-Induced Pluripotent Stem Cells to Repair Ovarian Function in a Chemotherapy-Induced Mouse Model of Premature Ovarian Failure

  2013cites this paper
• Pluripotent stem cells and gene therapy.

  2013cites this paper
• Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy.

  2013cites this paper
• Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?

  2013cites this paper
• Induced pluripotent stem cells and cell therapy

  2013cites this paper
• Induced Pluripotent Stem Cells: TherapeuticApplications in Monogenic and Metabolic Diseases, andRegulatory and Bioethical considerations.

  2013cites this paper
• Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

  2013cites this paper
• The Pharmacology of Regenerative Medicine

  2013cites this paper
• Construction of Human Embryonic Stem Cell Banks: Prospects for Tissue Matching

  2013cites this paper
• Metabolome and metaboproteome remodeling in nuclear reprogramming

  2013cites this paper
• iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery

  2013cites this paper